Please use this identifier to cite or link to this item:
Title: Study of Warme Shoab Muzmin (Chronic Bronchitis) with therapeutic evaluation of a Unani formulation
Authors: Shah, A H
Haji, A
Siddiqui, M A
Ansari, A N
Sofi, G
Keywords: Warme Shoab Muzmin;Chronic bronchitis;Unani medicine;Spirometry
Issue Date: Oct-2011
Publisher: NISCAIR-CSIR, India
IPC Code: Int. Cl.8: A01D 11/00, A01D 11/07, A01D 11/08, A01D 11/18
Abstract: The study was conducted as a single blind, randomized and standard controlled trial. Forty patients of Warme Shoab Muzmin were selected and randomly assigned to control and test groups; comprising 20 patients in each group. Test formulation consisting Aslussoos (Glycyrrhiza glabra), Parsiyaoshan (Adiantum capillus veresis), Zufa yabis (Hyssopus officinalis) and Sapistan (Cordia dichotoma) was given to the test group in the dose of 20 gm/day in decoction form for 45 days. The standard group received Ambroxol as a standard drug in the dose of 75 mg in tablet form once a day orally for 45 days. All the patients were assessed for subjective and objective parameters. The results were analyzed statistically using Mann- Whitney test ‘U’, Wilcoxon matched pairs signed rank test and student’s ‘t’ test. The test drug exhibited statistically significant improvement in cough (p<0.004), sputum production (p<0.001), and breathlessness (p<0.0146) in subjective parameters in comparison to control group. A significant improvement was also observed in wheezes (p<0.004), chest X- Ray findings (p<0.0477), and spirometric measures consisting of FEV1 % predicted (p<0.01), FEV1/FVC % (p<0.019), and PEF (p<0.03).
Page(s): 706-710
ISSN: 0975-1068 (Online); 0972-5938 (Print)
Appears in Collections:IJTK Vol.10(4) [October 2011]

Files in This Item:
File Description SizeFormat 
IJTK 10(4) 706-710.pdf75.27 kBAdobe PDFView/Open

Items in NOPR are protected by copyright, with all rights reserved, unless otherwise indicated.